Brief: Profusa U.S. Study Met Primary End Points As Presented At Late Breaking Clinical Trials At Paris Vascular Insights 2025
15/12/2025 12:33
Dec 15 (Reuters) - Profusa Inc PFSA.O: PROFUSA U.S. STUDY MET PRIMARY END POINTS AS PRESENTED AT LATE BREAKING CLINICAL TRIALS AT PARIS VASCULAR INSIGHTS 2025 Source text: ID:nGNX4sZSkj Further company coverage: PFSA.O ((Reuters.Briefs@thomsonreuters.com;))